Morning Overview on MSN
Nanoparticle therapy targets lung tumors and cancer-related muscle loss
A team at Oregon State University has engineered lipid nanoparticles that deliver messenger RNA to lung tumors while ...
Penn Engineers have redesigned a key component of lipid nanoparticles (LNPs), the delivery vehicles behind mRNA vaccines, to steer the particles toward lymph nodes while reducing off-target delivery ...
Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious ...
Researchers have redesigned lipid nanoparticles to make mRNA vaccine delivery more precise, reducing off-target effects.
A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose. (Nanowerk News) In studies in mice, the researchers showed that an mRNA influenza ...
A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting white blood cells, which play a crucial role in coordinating the immune ...
Vaccines that resemble viruses generally produce a stronger immune response, while mRNA versions are much quicker and cheaper to make. Now we are getting the best of both worlds, in the form of mRNA ...
Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively with tumors and deliver mRNA therapy with minimal off-target effects. That ...
ITHACA, N.Y. – A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient that may trigger ...
The most common side effects of mRNA vaccines like the COVID-19 shot are well known: soreness, mild fever and general malaise. Those symptoms, which typically resolve within days, are the natural ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results